ProKidney Corp (NASDAQ: PROK) on Monday, soared 19.43% from the previous trading day, before settling in for the closing price of $1.75. Within the past 52 weeks, PROK’s price has moved between $1.12 and $13.51.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The company achieved an average annual earnings per share of -67.37%. With a float of $43.22 million, this company’s outstanding shares have now reached $59.88 million.
Let’s determine the extent of company efficiency that accounts for 163 employees.
ProKidney Corp (PROK) Breakdown of a Key Holders of the stock
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of ProKidney Corp is 29.87%, while institutional ownership is 57.33%. The most recent insider transaction that took place on Nov 19 ’23, was worth 9,498,584. In this transaction Former 10% Owner of this company sold 7,256,367 shares at a rate of $1.31, taking the stock ownership to the 0 shares. Before that another transaction happened on Nov 17 ’23, when Company’s 10% Owner sold 258,400 for $1.19, making the entire transaction worth $308,400. This insider now owns 5,183,367 shares in total.
ProKidney Corp (PROK) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of 2.09 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -67.37% per share during the next fiscal year.
ProKidney Corp (NASDAQ: PROK) Trading Performance Indicators
ProKidney Corp (PROK) is currently performing well based on its current performance indicators. A quick ratio of 14.94 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.57, a number that is poised to hit -0.35 in the next quarter and is forecasted to reach -0.43 in one year’s time.
Technical Analysis of ProKidney Corp (PROK)
Looking closely at ProKidney Corp (NASDAQ: PROK), its last 5-days average volume was 1.53 million, which is a jump from its year-to-date volume of 0.59 million. As of the previous 9 days, the stock’s Stochastic %D was 80.27%. Additionally, its Average True Range was 0.18.
During the past 100 days, ProKidney Corp’s (PROK) raw stochastic average was set at 72.80%, which indicates a significant increase from 66.73% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 105.68% in the past 14 days, which was lower than the 114.27% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.4900, while its 200-day Moving Average is $4.3300. However, in the short run, ProKidney Corp’s stock first resistance to watch stands at $2.4500. Second resistance stands at $2.8100. The third major resistance level sits at $3.1900. If the price goes on to break the first support level at $1.7100, it is likely to go to the next support level at $1.3300. Now, if the price goes above the second support level, the third support stands at $0.9700.
ProKidney Corp (NASDAQ: PROK) Key Stats
Market capitalization of the company is 128.79 million based on 229,344K outstanding shares. Right now, sales total 0 K and income totals -35,470 K. The company made 0 K in profit during its latest quarter, and -5,700 K in sales during its previous quarter.
